AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.